Memo of Meeting Date: August 7, 2002 Representing Daon, Co. of Dublin Ireland: James Dunn, Senior Technical Sales Consultant Martin Walsh, VP Regulatory Affairs Representing FDA:

First Page		Document Content
Date: 2002-10-15 16:55:20 Surveillance Biometrics Identification Food and Drug Administration Title 21 CFR Part 11 Electronic signature Daon Inc. Pharmaceutical sciences Security Medicine		Memo of Meeting Date: August 7, 2002 Representing Daon, Co. of Dublin Ireland: James Dunn, Senior Technical Sales Consultant Martin Walsh, VP Regulatory Affairs Representing FDA: Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 38,51 KB Share Document on Facebook

	508 Checklist FINAL REVISED10-8-14.xls DocID: 1r6Jh - View Document
	Civil Aviation Safety Regulations 1998 Statutory Rules 1998 No. 237 as amended made under the Civil Aviation Act 1988 DocID: 1qR0c - View Document
	Federal Register / Vol. 81, NoMonday, March 21, Rules and Regulations List of Subjects in 21 CFR Part 14 DocID: 1qQyE - View Document
	PDF Document DocID: 1qKzO - View Document
	Data Integrity and Compliance With CGMP Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. DocID: 1q6Px - View Document